Thursday, 1 October
Breaking News: Faricimab's Real-World Impact
1 October, 13:30 – 14:30 CEST
Room 2
Chairperson:
A. Khanani (USA)
EURETINA IME Platform: The Future of Vitreoretinal Surgery: From Digital Visualisation Technologies to Real-World Adoption
1 October, 13:30 – 14:30 CEST
Room 4
Chairperson:
M. Zinkernagel (Switzerland)
Evolving Retinal Care: From Trusted Foundations to Future Innovation
1 October, 13:30 – 14:30 CEST
Strauss 2
Chairperson:
R. Gale (UK)
Geographic Atrophy Patient Management: What Do You See? What Would You Do?
1 October, 13:30 – 14:30 CEST
Strauss 1
Chairperson:
A. Ambresin (Switzerland)
Overkill or Practical? A 2-Year Review of TowardPi OCT in Europe
1 October, 13:30 – 14:30 CEST
Schubert 1
Chairperson:
E. Lanterna (Italy)
From Pixels to Pathology: Bridging the Continuum from Subclinical to Clinical Diseases with Multimodal Imaging
1 October, 13:30 – 14:30 CEST
Schubert 4
Chairperson:
T. Sakamoto (Japan)
Friday, 2 October
Vision in Harmony: Orchestrating Retinal Care With Continuous Drug Delivery in Namd
2 October, 09:45 - 10:45 CEST
Room 4
Chairperson:
F. Holz (Germany)
Coming into Focus: Precision Approaches to DME
2 October, 09:45 - 10:45 CEST
Lehar 2
Chairpersons:
E. Midena (Italy)
L. Kodjikian (France)
Achieving Superior Efficiency in Vitreoretinal Surgery
2 October, 09:45 - 10:45 CEST
Stolz 1
Chairperson:
G. Scharioth (Germany)
Innovative Synergies Part 1: Visualizing Retinal Vasculature - Angiography‑Driven Insights in Retina Practice with OCTA, FA, and ICGA
2 October, 09:45 - 10:45 CEST
Strauss 1
Chairpersons:
M. Bolz (Austria)
A. Pollreisz (Austria)
Redefining the Management of nAMD: The Impact of Durability and Sustained Disease Control
2 October, 09:45 - 10:45 CEST
Schubert 1
Chairperson:
A. Khanani (USA)
From RWE to System Impact: AI-Guided Decision-Making in Retinal Care
2 October, 13:45 - 14:45 CEST
Room 2
Chairperson:
P. Lanzetta (Italy)
The nAMD evidence arena: Where data meets discussion
2 October, 13:45 - 14:45 CEST
Strauss 2
Chairperson:
S. Sadda (USA)
A New Era in Imaging: Ultra High Axial Resolution OCT | Debate on AI Biomarkers
2 October, 13:45 - 14:45 CEST
Stolz 1
Chairperson:
C. Chisholm (Germany)
Valeda PBM in Dry AMD: Biological Rationale to Clinical Findings
2 October, 13:45 - 14:45 CEST
Strauss 1
Chairperson:
L. Kodjikian (France)
Enhancing Clinical Understanding through Ultra-Widefield Imaging: Optos Innovations and Future Applications
2 October, 13:45 - 14:45 CEST
Schubert 1
Chairperson:
P. Stanga (UK)
Raising the Bar in Retinal Vascular Disease: The Promise and Premise of Next-Generation Ang-2/VEGF Dual Inhibition
2 October, 17:45 - 18:45 CEST
Stolz 1
Chairperson:
R. Singh (USA)
Exploring New Horizons in Retina: Sustained Drug Delivery with EYP-1901 in Wet AMD and DME
2 October, 17:45 - 18:45 CEST
Strauss 1
Chairperson:
A. Loewenstein (Israel)
Saturday, 3 October
Beyond clinical benefits: The wider value of faricimab
3 October, 10:15 - 11:15 CEST
Room 3
Chairperson:
I. Pearce (UK)
DME uncovered: Evolving management through pathophysiology
3 October, 10:15 - 11:15 CEST
Room 4
Chairperson:
U. Schmidt-Erfurth (Austria)
Euretina IME Platform: Preserving Vision in Dry AMD and Geographic Atrophy Patients Through Early Detection and Timely Intervention
3 October, 10:15 - 11:15 CEST
Lehar 2
Chairperson:
A. Tufnail (UK)
Intravitreal Gene Therapy With 4D-150: Advancing Clinical Evidence of a Potential Backbone Therapy in nAMD and DME
3 October, 10:15 - 11:15 CEST
Schubert 1
Chairperson:
G. Cheung (Singapore)
PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes
3 October, 10:15 - 11:15 CEST
Schubert 4
Chairpersons:
F. Holz (Germany)
R. Dolz-Marco (Spain)
The DME evidence arena: Where data meets discussion
3 October, 13:00 - 14:00 CEST
Strauss 2
Chairperson:
V. Sheth (USA)
From debate to decisions: simplifying practice across patient profiles
3 October, 13:00 - 14:00 CEST
Lehar 2
Chairperson:
T. Aslam (UK)
Innovative Synergies Part 2: Integrating Cutting-Edge Visualization and Vitrectomy Technologies for Complex Case Management
3 October, 13:00 - 14:00 CEST
Strauss 1
Chairperson:
M. Bolz (Austria)
A New Standard in Multimodal Eye Imaging
3 October, 13:00 - 14:00 CEST
Schubert 1
Chairperson:
A. Chalecki (Poland)